A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina)

Ann Neurol. 1994 Mar;35(3):349-53. doi: 10.1002/ana.410350316.

Abstract

We report on a 12-year-old boy with the myopathic form of phosphoglycerate kinase (PGK) deficiency, and unique kinetic and physical characteristics of the mutant enzyme (PGK North Carolina). A G-to-T substitution at the 5' end of intron 4 was identified in the PGK gene of this patient. The mutation destroys the consensus sequence GT at the 5' splice junction of the intron. Activation of a cryptic splice site within intron 4 causes the insertion into the transcript of a 30-bp fragment at the 5' end of intron 4. This insertion results in ten additional amino acids within the "nose" of the PGK molecule, but does not generate a frameshift or a premature stop codon.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Child
  • DNA Mutational Analysis
  • Humans
  • Introns
  • Male
  • Molecular Sequence Data
  • Muscular Diseases / enzymology*
  • Muscular Diseases / genetics*
  • Phosphoglycerate Kinase / deficiency*
  • Phosphoglycerate Kinase / genetics*
  • Point Mutation*
  • Polymerase Chain Reaction
  • RNA Splicing / genetics

Substances

  • Phosphoglycerate Kinase